Impairment of the hemostatic potential of platelets during storage as evaluated by flow cytometry, thrombin generation, and thrombelastography under conditions promoting formation of coated platelets

Transfusion

Volumn 47, Issue 11, 2007, Pages 2057-2065

  Svendsen, Mette S ^b   Rojkjaer, Rasmus ^b   Kristensen, Annemarie T ^b   Salado Jimena, José A ^b   Kjalke, Marianne ^a   Johansson, Pär I ^b  

^a NOVO NORDISK A S   (Denmark)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CONVULXIN; THROMBIN; THROMBOCYTE CONCENTRATE;

ARTICLE; BLOOD ANALYSIS; BLOOD CLOTTING; BLOOD VESSEL INJURY; CONTROLLED STUDY; FIBRINOLYSIS; FLOW CYTOMETRY; HEMOSTASIS; HUMAN; QUALITY CONTROL; THROMBIN TIME; THROMBOCYTE ACTIVATION; THROMBOCYTE PRESERVATION; THROMBOCYTOPOIESIS; THROMBOELASTOGRAPHY;

BLOOD PLATELETS; BLOOD PRESERVATION; FLOW CYTOMETRY; HEMOSTASIS; HUMANS; PLATELET ACTIVATION; THROMBELASTOGRAPHY; THROMBIN; TIME FACTORS;

EID: 35448985399     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2007.01430.x     Document Type: Article

References (41)

1. Heal JM, Blumberg N. Optimizing platelet transfusion therapy. Blood Rev 2004 18 : 149 65.
2. Cardigan R, Williamson LM. The quality of platelets after storage for 7 days. Transfus Med 2003 13 : 173 87.
3. Guide to the preparation use and quality assurance of blood components. Recommendation R(95)15, 11th ed. Strasbourg : Council of Europe Publishing 2005. p. 1 22 6.
4. Standards for blood banks and transfusion services. 19th ed. Bethesda : American Association of Blood Banks 1999. p. 2 9 30.
5. Curvers J, van Pampus EC, Feijge MA, Rombout-Sestrienkova E, Giesen PL, Heemskerk JW. Decreased responsiveness and development of activation markers of PLTs stored in plasma. Transfusion 2004 44 : 49 58.
6. Alberio L, Friese P, Clemetson KJ, Dale GL. Collagen response and glycoprotein VI function decline progressively as canine platelets age in vivo. Thromb Hemost 2002 88 : 510 16.
7. Alberio L, Clemetson KJ. All platelets are not equal: COAT platelets. Curr Hematol Rep 2004 3 : 338 43.
8. Dale GL. Coated-platelets: an emerging component of the procoagulant response. J Thromb Hemost 2005 3 : 2185 92.
9. Alberio L, Safa O, Clemetson KJ, Esmon CT, Dale GL. Surface expression and functional characterization of α-granule factor V in human platelets. effects of ionophore A23187, thrombin, collagen, and convulxin. Blood 2000 95 : 1694 702.
10. Kempton CL, Hoffman M, Roberts HR, Monroe DM. Platelet heterogeneity: variation in coagulation complexes on platelet subpopulations. Arterioscler Thromb Vasc Biol 2005 25 : 861 6.
11. Jandrot-Perrus M, Lagrue AH, Okuma M, Bon C. Adhesion and activation of human platelets induced by convulxin involve glycoprotein VI and integrin α2β1. J Biol Chem 1997 272 : 27035 41.
12. Hemker HC, Giesen P, Al Dieri R, Regnault V, de Smedt E, Wagenvoord R, Lecompte T, Beguin S. Calibrated automated thrombin generation measurement in clotting plasma. Pathophysiol Hemost Thromb 2003 33 : 4 15.
13. Bertolini F, Murphy S. A multicenter inspection of the swirling phenomenon in platelet concentrates prepared in routine practice. Biomedical Excellence for Safer Transfusion (BEST) Working Party of the International Society of Blood Transfusion. Transfusion 1996 36 : 128 32.
14. Severinghaus JW. Blood gas calculator. J Appl Physiol 1966 21 : 1108 16.
15. Michelson AD. Flow cytometry: a clinical test of platelet function. Blood 1996 87 : 4925 36.
16. Kjalke M, Kjellev S, Rojkjaer R. Preferential localization of recombinant factor VIIa to platelets activated with a combination of thrombin and glycoprotein VI receptor agonist. J Thromb Hemost 2007 5 : 774 80.
17. Nielsen VG. Effects of aprotinin on plasma coagulation kinetics determined by thrombelastography: role of Factor XI. Acta Anaesthesiol Scand 2006 50 : 168 72.
18. Katori N, Tanaka KA, Szlam F, Levy JH. The effects of platelet count on clot retraction and tissue plasminogen activator-induced fibrinolysis on thrombelastography. Anesth Analg 2005 100 : 1781 5.
19. TEG 5000 hemostasis analyzer hemoscope, user manual. Niles (IL) : Haemoscope Corp. 2002. p. 1 10.
20. Dunnett CW. A multiple comparison procedure for comparing several treatments with a control. J Am Stat Assoc 1955 50 : 1096 121.
21. Holme S, Heaton A. In vitro platelet ageing at 22°C is reduced compared to in vivo ageing at 37°C. Br J Haematol 1995 91 : 212 18.
22. Bergmeier W, Burger PC, Piffath CL, Hoffmeister KM, Hartwig JH, Nieswandt B, Wagner DD. Metalloproteinase inhibitors improve the recovery and hemostatic function of in vitro-aged or -injured mouse platelets. Blood 2003 102 : 4229 35.
23. Bergmeier W, Rabie T, Strehl A, Piffath CL, Prostredna M, Wagner DD, Nieswandt B. GPVI down-regulation in murine platelets through metalloproteinase-dependent shedding. Thromb Hemost 2004 91 : 951 8.
24. Badlou BA, Ijseldijk MJ, Smid WM, Akkerman JW. Prolonged platelet preservation by transient metabolic suppression. Transfusion 2005 45 : 214 22.
25. Vetlesen A, Mirlashari MR, Torsheim IA, Kjeldsen-Kragh J. Platelet activation and residual activation potential during storage of hyperconcentrated platelet products in two different platelet additive solutions. Transfusion 2005 45 : 1349 55.
26. Keuren JF, Magdeleyns EJ, Govers-Riemslag JW, Lindhout T, Curvers J. Effects of storage-induced platelet microparticles on the initiation and propagation phase of blood coagulation. Br J Haematol 2006 134 : 307 13.
27. Hemker HC, Beguin S. Thrombin generation in plasma: its assessment via the endogenous thrombin potential. Thromb Hemost 1995 74 : 134 8.
28. Mann KG. Biochemistry and physiology of blood coagulation. Thromb Hemost 1999 82 : 165 74.
29. Brummel KE, Butenas S, Mann KG. An integrated study of fibrinogen during blood coagulation. J Biol Chem 1999 274 : 22862 70.
30. Bajzar L, Manuel R, Nesheim ME. Purification and characterization of TAFI, a thrombin-activable fibrinolysis inhibitor. J Biol Chem 1995 270 : 14477 84.
31. Ariens RA, Lai TS, Weisel JW, Greenberg CS, Grant PJ. Role of factor XIII in fibrin clot formation and effects of genetic polymorphisms. Blood 2002 100 : 743 54.
32. Redlitz A, Tan AK, Eaton DL, Plow EF. Plasma carboxypeptidases as regulators of the plasminogen system. J Clin Invest 1995 96 : 2534 8.
33. Mosnier LO, dem Borne PA, Meijers JC, Bouma BN. Plasma TAFI levels influence the clot lysis time in healthy individuals in the presence of an intact intrinsic pathway of coagulation. Thromb Hemost 1998 80 : 829 35.
34. Veklich Y, Francis CW, White J, Weisel JW. Structural studies of fibrinolysis by electron microscopy. Blood 1998 92 : 4721 9.
35. Collet JP, Park D, Lesty C, Soria J, Soria C, Montalescot G, Weisel JW. Influence of fibrin network conformation and fibrin fiber diameter on fibrinolysis speed - dynamic and structural approaches by confocal microscopy. Arterioscler Thromb Vasc Biol 2000 20 : 1354 61.
36. Gabriel DA, Muga K, Boothroyd EM. The effect of fibrin structure on fibrinolysis. J Biol Chem 1992 267 : 24259 63.
37. Shanwell A, Diedrich B, Falker C, Jansson B, Sandgren P, Sundkvist L, Svensson L, Vesterinen M, Gulliksson H. Paired in vitro and in vivo comparison of apheresis platelet concentrates stored in platelet additive solution for 1 versus 7 days. Transfusion 2006 46 : 973 9.
38. Rinder HM, Snyder EL. Activation of platelet concentrate during preparation and storage. Blood Cells 1992 18 : 445 56.
39. Murphy S, Gardner FH. Platelet storage at 22 degrees C; metabolic, morphologic, and functional studies. J Clin Invest 1971 50 : 370 7.
40. Filip DJ, Aster RH. Relative hemostatic effectiveness of human platelets stored at 4 degrees and 22 degrees C. J Lab Clin Med 1978 91 : 618 24.
41. Owens M, Holme S, Heaton A, Sawyer S. Post-transfusion recovery of function of 5-day stored platelet concentrates. Br J Haematol 1992 80 : 539 44.